Familial and sporadic fatal insomnia

Pasquale Montagna1, Pierluigi Gambetti, Pietro Cortelli

  • 1Department of Neurological Sciences, University of Bologna, Bologna, Italy.

The Lancet. Neurology
|July 10, 2003
PubMed

Insights

Familial fatal insomnia (FFI) and sporadic fatal insomnia (SFI) share symptoms like disrupted sleep and motor issues. Distinct prion strains and PRNP gene variations influence these rare prion diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Familial fatal insomnia (FFI) and sporadic fatal insomnia (SFI) are rare prion diseases with overlapping clinical presentations.
  • Both conditions involve severe disruptions in sleep architecture, autonomic dysfunction, and progressive motor deficits.

Purpose of the Study:

  • To delineate the clinicopathological features of FFI and SFI.
  • To investigate the role of PRNP gene mutations and polymorphisms in disease phenotype.
  • To explore the potential for distinct prion strains in FFI.

Main Methods:

  • Clinical assessment of sleep disturbances, autonomic hyperactivation, and motor abnormalities.
  • Positron Emission Tomography (PET) for metabolic activity.
  • Neuropathological examination of brain tissue.
  • Analysis of prion protein (PrP) isoforms and PRNP gene mutations (D178N) and polymorphisms (codon 129).

Main Results:

  • FFI and SFI exhibit similar phenotypes including disrupted sleep (loss of sleep spindles, slow-wave sleep, enacted dreams) and autonomic/motor signs (myoclonus, ataxia, dysarthria, dysphagia, pyramidal signs).
  • PET imaging revealed significant thalamic and limbic hypometabolism, progressing to wider brain regions.
  • Neuropathology showed severe neuronal loss and astrogliosis in the anterior medial thalamus and inferior olives, with later involvement of cerebral cortex and cerebellum.
  • Distinct PrP isoforms were identified in FFI compared to familial Creutzfeldt-Jakob disease with the same D178N mutation, highlighting the influence of the PRNP codon 129 polymorphism on prion strain characteristics.

Conclusions:

  • The thalamolimbic system plays a crucial role in regulating sleep and circadian functions, as suggested by clinicopathological findings in FFI and SFI.
  • The PRNP codon 129 polymorphism significantly impacts the phenotypic expression of the D178N mutation, potentially leading to different prion strains.
  • FFI and SFI represent distinct but related prionopathies with shared neuropathological substrates and clinical manifestations.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...